These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34954485)

  • 1. Association between circulating microRNAs and the metabolic syndrome in adult populations: A systematic review.
    Solís-Toro D; Mosquera Escudero M; García-Perdomo HA
    Diabetes Metab Syndr; 2022 Jan; 16(1):102376. PubMed ID: 34954485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between circulating microRNAs and chronotypical features in subjects with metabolic syndrome.
    Assmann TS; Cuevas-Sierra A; Salas-Pérez F; Riezu-Boj JI; Milagro FI; Martínez JA
    Chronobiol Int; 2020 Jul; 37(7):1048-1058. PubMed ID: 32633152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome.
    Mir FA; Mall R; Iskandarani A; Ullah E; Samra TA; Cyprian F; Parray A; Alkasem M; Abdalhakam I; Farooq F; Abou-Samra AB
    Front Endocrinol (Lausanne); 2022; 13():937089. PubMed ID: 35937842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study.
    Udesen PB; Sørensen AE; Svendsen R; Frisk NLS; Hess AL; Aziz M; Wissing MLM; Englund ALM; Dalgaard LT
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters.
    Zmyslowska A; Smyczynska U; Stanczak M; Jeziorny K; Szadkowska A; Fendler W; Borowiec M
    Front Endocrinol (Lausanne); 2022; 13():1057056. PubMed ID: 36506055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study.
    Raitoharju E; Seppälä I; Oksala N; Lyytikäinen LP; Raitakari O; Viikari J; Ala-Korpela M; Soininen P; Kangas AJ; Waldenberger M; Klopp N; Illig T; Leiviskä J; Loo BM; Hutri-Kähönen N; Kähönen M; Laaksonen R; Lehtimäki T
    Mol Cell Endocrinol; 2014 Jun; 391(1-2):41-9. PubMed ID: 24784704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory miRNA biomarkers of metabolic syndrome.
    Ramzan F; D'Souza RF; Durainayagam BR; Milan AM; Markworth JF; Miranda-Soberanis V; Sequeira IR; Roy NC; Poppitt SD; Mitchell CJ; Cameron-Smith D
    Acta Diabetol; 2020 Feb; 57(2):203-214. PubMed ID: 31435783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.
    Sud N; Zhang H; Pan K; Cheng X; Cui J; Su Q
    J Nutr Biochem; 2017 May; 43():125-131. PubMed ID: 28284064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNAs in male subfertility-biomarkers and a potential pathogenetic link to metabolic syndrome.
    Trzybulska D; Bobjer J; Giwercman A; Tsatsanis C
    J Assist Reprod Genet; 2017 Oct; 34(10):1277-1282. PubMed ID: 28664228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity.
    Al-Rawaf HA
    Clin Nutr; 2019 Oct; 38(5):2231-2238. PubMed ID: 30309709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of microRNAs in heart failure: A meta-analysis.
    Yang J; Yang XS; Fan SW; Zhao XY; Li C; Zhao ZY; Pei HJ; Qiu L; Zhuang X; Yang CH
    Medicine (Baltimore); 2021 Nov; 100(46):e27744. PubMed ID: 34797300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adiposity-related microRNAs as predictors of the response to a low-fat diet in subjects with obesity.
    Assmann TS; Riezu-Boj JI; Milagro FI; Martínez JA
    J Cell Mol Med; 2020 Mar; 24(5):2956-2967. PubMed ID: 31968396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome.
    Doghish AS; Elsisi AM; Amin AI; Abulsoud AI
    Can J Diabetes; 2021 Oct; 45(7):614-618. PubMed ID: 33582040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-based microRNA signatures in early diagnosis of breast cancer.
    Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
    Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA levels differ in the early stages of insulin resistance in prepubertal children with obesity.
    Santos D; Porter-Gill P; Goode G; Delhey L; Sørensen AE; Rose S; Børsheim E; Dalgaard LT; Carvalho E
    Life Sci; 2023 Jan; 312():121246. PubMed ID: 36455651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
    Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
    Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients.
    Muendlein A; Geiger K; Leiherer A; Saely CH; Fraunberger P; Drexel H
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F315-F321. PubMed ID: 31813253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
    Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
    Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
    Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
    Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.
    Ma E; Fu Y; Garvey WT
    Metab Syndr Relat Disord; 2018 Mar; 16(2):82-89. PubMed ID: 29360415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.